Everest Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 7:48 pm

Market Cap	414 Cr.
Current Price	426
High / Low	477/112
Stock P/E
Book Value	72.0
Dividend Yield	0.00 %
ROCE	1.76 %
ROE	2.23 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Everest Organics Ltd

Competitors of Everest Organics Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	134 Cr.	95.0	247/84.3	26.0	41.7	0.00 %	12.9 %	9.75 %	10.0
MPS Pharmaa Ltd	5.27 Cr.	2.76	4.33/2.50		0.57	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	39.9 Cr.	53.8	94.9/44.5		8.73	0.00 %	41.5 %	14.4 %	10.0
Gujarat Inject (Kerala) Ltd	41.1 Cr.	28.0	29.1/13.1	40.3	6.83	0.00 %	13.5 %	11.0 %	10.0
Industry Average	18,354.98 Cr	1,129.60		88.53	194.54	0.32%	16.70%	15.22%	6.19

All Competitor Stocks of Everest Organics Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	55.10	43.03	45.97	43.29	50.75	42.67	49.45	52.51	52.62	32.45	44.05	42.05	40.93
Expenses	53.36	44.67	43.20	45.79	48.47	40.15	46.74	49.71	49.67	36.11	40.62	38.03	37.49
Operating Profit	1.74	-1.64	2.77	-2.50	2.28	2.52	2.71	2.80	2.95	-3.66	3.43	4.02	3.44
OPM %	3.16%	-3.81%	6.03%	-5.78%	4.49%	5.91%	5.48%	5.33%	5.61%	-11.28%	7.79%	9.56%	8.40%
Other Income	0.45	0.39	0.22	5.65	0.69	0.22	0.24	0.13	0.30	0.33	0.14	0.00	0.22
Interest	1.00	0.69	0.85	0.81	0.95	1.29	1.49	1.45	1.24	1.29	1.35	1.40	1.15
Depreciation	0.77	0.99	1.13	1.10	1.26	1.29	1.32	1.33	1.85	1.47	1.47	1.47	1.56
Profit before tax	0.42	-2.93	1.01	1.24	0.76	0.16	0.14	0.15	0.16	-6.09	0.75	1.15	0.95
Tax %	28.57%	-5.80%	6.93%	-21.77%	85.53%	75.00%	78.57%	93.33%	62.50%	0.00%	0.00%	0.87%	-206.32%
Net Profit	0.29	-2.75	0.94	1.52	0.11	0.04	0.03	0.02	0.06	-6.09	0.75	1.14	2.91
EPS in Rs	0.36	-3.44	1.18	1.90	0.14	0.05	0.04	0.02	0.08	-7.61	0.94	1.42	3.00

Last Updated: May 31, 2025, 6:06 am

Below is a detailed analysis of the quarterly data for Everest Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 40.93 Cr.. The value appears to be declining and may need further review. It has decreased from 42.05 Cr. (Dec 2024) to 40.93 Cr., marking a decrease of 1.12 Cr..
For Expenses, as of Mar 2025, the value is 37.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 38.03 Cr. (Dec 2024) to 37.49 Cr., marking a decrease of 0.54 Cr..
For Operating Profit, as of Mar 2025, the value is 3.44 Cr.. The value appears to be declining and may need further review. It has decreased from 4.02 Cr. (Dec 2024) to 3.44 Cr., marking a decrease of 0.58 Cr..
For OPM %, as of Mar 2025, the value is 8.40%. The value appears to be declining and may need further review. It has decreased from 9.56% (Dec 2024) to 8.40%, marking a decrease of 1.16%.
For Other Income, as of Mar 2025, the value is 0.22 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 0.22 Cr., marking an increase of 0.22 Cr..
For Interest, as of Mar 2025, the value is 1.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.40 Cr. (Dec 2024) to 1.15 Cr., marking a decrease of 0.25 Cr..
For Depreciation, as of Mar 2025, the value is 1.56 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.47 Cr. (Dec 2024) to 1.56 Cr., marking an increase of 0.09 Cr..
For Profit before tax, as of Mar 2025, the value is 0.95 Cr.. The value appears to be declining and may need further review. It has decreased from 1.15 Cr. (Dec 2024) to 0.95 Cr., marking a decrease of 0.20 Cr..
For Tax %, as of Mar 2025, the value is -206.32%. The value appears to be improving (decreasing) as expected. It has decreased from 0.87% (Dec 2024) to -206.32%, marking a decrease of 207.19%.
For Net Profit, as of Mar 2025, the value is 2.91 Cr.. The value appears strong and on an upward trend. It has increased from 1.14 Cr. (Dec 2024) to 2.91 Cr., marking an increase of 1.77 Cr..
For EPS in Rs, as of Mar 2025, the value is 3.00. The value appears strong and on an upward trend. It has increased from 1.42 (Dec 2024) to 3.00, marking an increase of 1.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 1:11 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	80	96	106	99	107	112	156	167	182	200	183	197	171
Expenses	74	91	98	94	101	105	138	148	159	194	182	186	164
Operating Profit	5	5	8	6	6	7	18	19	23	6	1	11	7
OPM %	7%	6%	7%	6%	6%	6%	11%	12%	13%	3%	1%	6%	4%
Other Income	0	1	-0	-0	1	1	1	1	1	2	7	1	1
Interest	3	3	3	3	3	3	3	3	3	3	3	5	5
Depreciation	2	2	3	3	2	3	3	3	3	4	4	6	6
Profit before tax	1	1	2	0	2	2	12	14	17	2	0	1	-4
Tax %	22%	21%	20%	18%	24%	28%	39%	23%	21%	34%	311%	77%
Net Profit	1	1	2	0	1	2	8	11	14	1	-0	0	-4
EPS in Rs				0.54	1.69	2.14	9.39	13.62	17.15	1.42	-0.22	0.18	-5.17
Dividend Payout %	0%	0%	0%	0%	0%	0%	11%	7%	9%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023
YoY Net Profit Growth (%)	0.00%	100.00%	-100.00%	100.00%	300.00%	37.50%	27.27%	-92.86%	-100.00%
Change in YoY Net Profit Growth (%)	0.00%	100.00%	-200.00%	200.00%	200.00%	-262.50%	-10.23%	-120.13%	-7.14%

Everest Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2013-2014 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:	4%
5 Years:	-1%
3 Years:	-7%
TTM:	-19%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-1021%

Stock Price CAGR
10 Years:	%
5 Years:	36%
3 Years:	42%
1 Year:	248%

Return on Equity
10 Years:	11%
5 Years:	6%
3 Years:	-1%
Last Year:	-2%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 1:48 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	9	9	9	3	8	8	8	8	8	8	8	8	8
Reserves	-5	-5	-3	3	8	11	18	26	39	39	38	38	32
Borrowings	19	26	24	28	19	22	21	18	23	39	51	58	51
Other Liabilities	33	35	37	42	51	54	60	68	66	92	105	123	128
Total Liabilities	56	65	67	76	86	94	107	120	135	178	202	227	220
Fixed Assets	22	24	24	27	33	34	38	39	44	49	54	52	51
CWIP	1	0	0	1	1	1	0	1	0	8	12	21	21
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	33	41	42	47	52	60	68	80	92	121	136	153	148
Total Assets	56	65	67	76	86	94	107	120	135	178	202	227	220

Below is a detailed analysis of the balance sheet data for Everest Organics Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
For Reserves, as of Sep 2024, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2024) to 32.00 Cr., marking a decrease of 6.00 Cr..
For Borrowings, as of Sep 2024, the value is 51.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 58.00 Cr. (Mar 2024) to 51.00 Cr., marking a decrease of 7.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 123.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 5.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 220.00 Cr.. The value appears to be improving (decreasing). It has decreased from 227.00 Cr. (Mar 2024) to 220.00 Cr., marking a decrease of 7.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Mar 2024) to 51.00 Cr., marking a decrease of 1.00 Cr..
For CWIP, as of Sep 2024, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 148.00 Cr.. The value appears to be declining and may need further review. It has decreased from 153.00 Cr. (Mar 2024) to 148.00 Cr., marking a decrease of 5.00 Cr..
For Total Assets, as of Sep 2024, the value is 220.00 Cr.. The value appears to be declining and may need further review. It has decreased from 227.00 Cr. (Mar 2024) to 220.00 Cr., marking a decrease of 7.00 Cr..

However, the Borrowings (51.00 Cr.) are higher than the Reserves (₹32.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	1	4	7	10	5	9	10	14	14	18	16
Cash from Investing Activity +	-3	-3	-7	-8	-4	-5	-6	-12	-17	-16	-13
Cash from Financing Activity +	2	-2	-0	-2	-1	-3	-3	-2	2	-3	-3
Net Cash Flow	0	-0	0	0	-0	1	0	-0	-1	0	0

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-14.00	-21.00	-16.00	-22.00	-13.00	-15.00	-3.00	1.00	0.00	-33.00	-50.00	-47.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	91	106	100	117	105	124	95	97	102	125	152	185
Inventory Days	55	46	44	55	73	72	71	102	110	110	139	128
Days Payable	164	184	184	235	260	251	190	211	183	212	282	324
Cash Conversion Cycle	-18	-32	-40	-63	-83	-55	-24	-12	29	24	9	-11
Working Capital Days	-22	8	7	6	-15	7	18	30	55	59	67	60
ROCE %	15%	13%	19%	11%	13%	13%	35%	35%	34%	6%	4%	6%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%	74.15%
DIIs	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Public	25.82%	25.82%	25.82%	25.82%	25.82%	25.82%	25.83%	25.83%	25.82%	25.82%	25.83%	25.83%
No. of Shareholders	10,784	11,135	11,154	11,244	11,250	11,100	10,834	10,634	10,494	10,242	10,023	9,792

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.17	-0.23	1.43	17.14	13.62
Diluted EPS (Rs.)	0.17	-0.23	1.43	17.14	13.62
Cash EPS (Rs.)	7.42	5.36	6.17	21.36	17.63
Book Value[Excl.RevalReserv]/Share (Rs.)	57.30	57.77	58.50	58.22	42.75
Book Value[Incl.RevalReserv]/Share (Rs.)	57.30	57.77	58.50	58.22	42.75
Dividend / Share (Rs.)	0.00	0.00	0.50	1.50	1.00
Revenue From Operations / Share (Rs.)	246.55	228.81	250.06	226.96	209.01
PBDIT / Share (Rs.)	14.84	9.84	10.80	29.88	25.77
PBIT / Share (Rs.)	7.60	4.25	6.05	25.66	21.76
PBT / Share (Rs.)	0.76	0.11	2.17	21.59	17.61
Net Profit / Share (Rs.)	0.17	-0.22	1.43	17.14	13.62
PBDIT Margin (%)	6.01	4.30	4.31	13.16	12.32
PBIT Margin (%)	3.08	1.85	2.42	11.30	10.41
PBT Margin (%)	0.30	0.04	0.86	9.51	8.42
Net Profit Margin (%)	0.07	-0.09	0.57	7.55	6.51
Return on Networth / Equity (%)	0.30	-0.39	2.44	29.44	31.85
Return on Capital Employeed (%)	9.12	5.28	7.39	35.38	37.61
Return On Assets (%)	0.06	-0.09	0.64	10.13	9.05
Long Term Debt / Equity (X)	0.31	0.25	0.23	0.12	0.13
Total Debt / Equity (X)	1.26	1.10	0.82	0.42	0.44
Asset Turnover Ratio (%)	0.92	0.96	1.28	1.42	1.47
Current Ratio (X)	0.93	0.96	1.05	1.15	1.07
Quick Ratio (X)	0.66	0.62	0.67	0.72	0.69
Inventory Turnover Ratio (X)	2.73	2.83	3.77	3.85	4.46
Dividend Payout Ratio (NP) (%)	0.00	-219.53	69.94	8.74	0.00
Dividend Payout Ratio (CP) (%)	0.00	9.32	16.19	7.02	0.00
Earning Retention Ratio (%)	0.00	319.53	30.06	91.26	0.00
Cash Earning Retention Ratio (%)	0.00	90.68	83.81	92.98	0.00
Interest Coverage Ratio (X)	2.17	2.38	2.78	7.34	6.22
Interest Coverage Ratio (Post Tax) (X)	1.03	0.94	1.37	5.21	4.29
Enterprise Value (Cr.)	148.80	126.35	177.17	202.22	89.18
EV / Net Operating Revenue (X)	0.75	0.69	0.88	1.11	0.53
EV / EBITDA (X)	12.53	16.05	20.51	8.46	4.33
MarketCap / Net Operating Revenue (X)	0.46	0.41	0.69	1.01	0.45
Retention Ratios (%)	0.00	319.53	30.05	91.25	0.00
Price / BV (X)	2.00	1.65	2.97	3.95	2.22
Price / Net Operating Revenue (X)	0.46	0.41	0.69	1.01	0.45
EarningsYield	0.00	0.00	0.01	0.07	0.14

After reviewing the key financial ratios for Everest Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 23) to 0.17, marking an increase of 0.40.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 23) to 0.17, marking an increase of 0.40.
For Cash EPS (Rs.), as of Mar 24, the value is 7.42. This value is within the healthy range. It has increased from 5.36 (Mar 23) to 7.42, marking an increase of 2.06.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 57.30. It has decreased from 57.77 (Mar 23) to 57.30, marking a decrease of 0.47.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 57.30. It has decreased from 57.77 (Mar 23) to 57.30, marking a decrease of 0.47.
For Dividend / Share (Rs.), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 246.55. It has increased from 228.81 (Mar 23) to 246.55, marking an increase of 17.74.
For PBDIT / Share (Rs.), as of Mar 24, the value is 14.84. This value is within the healthy range. It has increased from 9.84 (Mar 23) to 14.84, marking an increase of 5.00.
For PBIT / Share (Rs.), as of Mar 24, the value is 7.60. This value is within the healthy range. It has increased from 4.25 (Mar 23) to 7.60, marking an increase of 3.35.
For PBT / Share (Rs.), as of Mar 24, the value is 0.76. This value is within the healthy range. It has increased from 0.11 (Mar 23) to 0.76, marking an increase of 0.65.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 2. It has increased from -0.22 (Mar 23) to 0.17, marking an increase of 0.39.
For PBDIT Margin (%), as of Mar 24, the value is 6.01. This value is below the healthy minimum of 10. It has increased from 4.30 (Mar 23) to 6.01, marking an increase of 1.71.
For PBIT Margin (%), as of Mar 24, the value is 3.08. This value is below the healthy minimum of 10. It has increased from 1.85 (Mar 23) to 3.08, marking an increase of 1.23.
For PBT Margin (%), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 10. It has increased from 0.04 (Mar 23) to 0.30, marking an increase of 0.26.
For Net Profit Margin (%), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from -0.09 (Mar 23) to 0.07, marking an increase of 0.16.
For Return on Networth / Equity (%), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 15. It has increased from -0.39 (Mar 23) to 0.30, marking an increase of 0.69.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 5.28 (Mar 23) to 9.12, marking an increase of 3.84.
For Return On Assets (%), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.09 (Mar 23) to 0.06, marking an increase of 0.15.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.31. This value is within the healthy range. It has increased from 0.25 (Mar 23) to 0.31, marking an increase of 0.06.
For Total Debt / Equity (X), as of Mar 24, the value is 1.26. This value exceeds the healthy maximum of 1. It has increased from 1.10 (Mar 23) to 1.26, marking an increase of 0.16.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 0.96 (Mar 23) to 0.92, marking a decrease of 0.04.
For Current Ratio (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1.5. It has decreased from 0.96 (Mar 23) to 0.93, marking a decrease of 0.03.
For Quick Ratio (X), as of Mar 24, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.62 (Mar 23) to 0.66, marking an increase of 0.04.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.73. This value is below the healthy minimum of 4. It has decreased from 2.83 (Mar 23) to 2.73, marking a decrease of 0.10.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -219.53 (Mar 23) to 0.00, marking an increase of 219.53.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.32 (Mar 23) to 0.00, marking a decrease of 9.32.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 319.53 (Mar 23) to 0.00, marking a decrease of 319.53.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.68 (Mar 23) to 0.00, marking a decrease of 90.68.
For Interest Coverage Ratio (X), as of Mar 24, the value is 2.17. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 23) to 2.17, marking a decrease of 0.21.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.03. This value is below the healthy minimum of 3. It has increased from 0.94 (Mar 23) to 1.03, marking an increase of 0.09.
For Enterprise Value (Cr.), as of Mar 24, the value is 148.80. It has increased from 126.35 (Mar 23) to 148.80, marking an increase of 22.45.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.69 (Mar 23) to 0.75, marking an increase of 0.06.
For EV / EBITDA (X), as of Mar 24, the value is 12.53. This value is within the healthy range. It has decreased from 16.05 (Mar 23) to 12.53, marking a decrease of 3.52.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 23) to 0.46, marking an increase of 0.05.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 319.53 (Mar 23) to 0.00, marking a decrease of 319.53.
For Price / BV (X), as of Mar 24, the value is 2.00. This value is within the healthy range. It has increased from 1.65 (Mar 23) to 2.00, marking an increase of 0.35.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 23) to 0.46, marking an increase of 0.05.
For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.00.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Everest Organics Ltd as of June 1, 2025 is: 19.65

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Everest Organics Ltd is Overvalued by 95.39% compared to the current share price 426.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Everest Organics Ltd as of June 1, 2025 is: 10.47

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Everest Organics Ltd is Overvalued by 97.54% compared to the current share price 426.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -46.73%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 17.00%, which is a positive sign. The stock has a low average Working Capital Days of 23.33, which is a positive sign. The stock has a low average Cash Conversion Cycle of -23.00, which is a positive sign. The company has shown consistent growth in sales (142.77 cr) and profit (3.85 cr) over the years.	The company has higher borrowings (30.69) compared to reserves (18.38), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Everest Organics Ltd:
1. Net Profit Margin: 0.07%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.12% (Industry Average ROCE: 16.7%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 0.3% (Industry Average ROE: 15.22%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.03
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.66
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 88.53)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 1.26
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 197.24 Cr. and Equity Capital is Rs. 8.00 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Aroor Village, Sadasivpet Mandal, Sangareddy Dist. Telangana 502291	e.cs@everestorganicsltd.com www.everestorganicsltd.com

Management
Name	Position Held
Mr. Ramakrishnam Raju Kounparaju	Chairman & Ind.Director
Dr. Srikakarlapudi Sirisha	Managing Director
Mr. Srikakarlapudi Harikrishna	Whole Time Director
Mr. Kakarlapudi Sitarama Raju	Non Executive Director
Mr. Venkatasatyanarayana Murthy Chayaly	Independent Director
Mr. Prasad Venkata Satya Sundara Srikakolapu	Independent Director
Mr. Akella Parvathisem	Director - Technical

FAQ

What is the intrinsic value of Everest Organics Ltd?

Everest Organics Ltd's intrinsic value (as of 01 June 2025) is ₹19.65 — 95.39% lower the current market price of 426.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 414 Cr. market cap, FY2025-2026 high/low of ₹477/112, reserves of 32 Cr, and liabilities of 220 Cr.

What is the Market Cap of Everest Organics Ltd?

The Market Cap of Everest Organics Ltd is 414 Cr..

What is the current Stock Price of Everest Organics Ltd as on 01 June 2025?

The current stock price of Everest Organics Ltd as on 01 June 2025 is 426.

What is the High / Low of Everest Organics Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Everest Organics Ltd stocks is ₹477/112.

What is the Stock P/E of Everest Organics Ltd?

The Stock P/E of Everest Organics Ltd is .

What is the Book Value of Everest Organics Ltd?

The Book Value of Everest Organics Ltd is 72.0.

What is the Dividend Yield of Everest Organics Ltd?

The Dividend Yield of Everest Organics Ltd is 0.00 %.

What is the ROCE of Everest Organics Ltd?

The ROCE of Everest Organics Ltd is 1.76 %.

What is the ROE of Everest Organics Ltd?

The ROE of Everest Organics Ltd is 2.23 %.

What is the Face Value of Everest Organics Ltd?

The Face Value of Everest Organics Ltd is 10.0.